ACLARIS THERAPEUTICS Trademark

Trademark Overview

On Friday, May 13, 2016, a trademark application was filed for ACLARIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ACLARIS THERAPEUTICS trademark a serial number of 87036909. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, July 15, 2024. This trademark is owned by Aclaris Therapeutics, Inc.. The ACLARIS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical preparations, products and technology in the fields of dermatology; providing medical and scientific research information in the fields of dermatology, pharmaceuticals and clinical trials [ ; drug discovery services ]
aclaris therapeutics

General Information

Serial Number87036909
Word MarkACLARIS THERAPEUTICS
Filing DateFriday, May 13, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, July 15, 2024
Registration Number5551283
Registration DateTuesday, August 28, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2016

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of pharmaceutical preparations, products and technology in the fields of dermatology; providing medical and scientific research information in the fields of dermatology, pharmaceuticals and clinical trials [ ; drug discovery services ]

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 18, 2016
Primary Code042
First Use Anywhere DateSaturday, September 30, 2017
First Use In Commerce DateSaturday, September 30, 2017

Trademark Owner History

Party NameAclaris Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWayne, PA 19087
Party NameAclaris Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWayne, PA 19087
Party NameAclaris Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events

Event DateEvent Description
Tuesday, August 30, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 17, 2016NEW APPLICATION ENTERED
Wednesday, May 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 29, 2016ASSIGNED TO EXAMINER
Tuesday, December 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, August 30, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 30, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, August 30, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2016ASSIGNED TO LIE
Tuesday, September 20, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 5, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2016PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, June 16, 2018USE AMENDMENT FILED
Wednesday, May 31, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2017SOU EXTENSION 1 FILED
Wednesday, May 31, 2017SOU EXTENSION 1 GRANTED
Friday, June 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2017SOU EXTENSION 2 FILED
Wednesday, November 29, 2017SOU EXTENSION 2 GRANTED
Friday, December 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 16, 2018TEAS STATEMENT OF USE RECEIVED
Monday, June 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 10, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 10, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 24, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 25, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 28, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, August 30, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 30, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 4, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 4, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 1, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 22, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, November 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 28, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 3, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, July 15, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 15, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, July 15, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

therapeutics aclaris fields dermatology research pharmaceuticals clinical trials services discovery drug information